Indeed, another report showed that deletion of Cdkn2a/ARF led to hemangioma formation in only 6.1% of all tumors analyzed [198], suggesting that co-deletion of ARF changes the spectrum of tumors caused by Cdkn2a deletion in addition to an increase in lethality [156]. Here, CDKN2A is linked to hemangioma.